The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Epigenome Analysis Services Market Research Report 2025
Synopsis
The global Epigenome Analysis Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Epigenome Analysis Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Epigenome Analysis Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Epigenome Analysis Services in Research Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Epigenome Analysis Services include Cellcentric, Syndax, Illumina, Merck, QIAGEN, F. Hoffmann-La Roche, Eisai, Abcam and Diagenode, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Epigenome Analysis Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epigenome Analysis Services.
Report Scope
The Epigenome Analysis Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epigenome Analysis Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epigenome Analysis Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellcentric
Syndax
Illumina
Merck
QIAGEN
F. Hoffmann-La Roche
Eisai
Abcam
Diagenode
Active Motif
Zymo Research Corporation
Thermo Fisher Scientific
Enzo Life Sciences
EpiGentek Group
New England Biolabs
Epizyme
Domainex
Agilent Technologies
AsisChem
Segment by Type
DNA Methylation Analysis
Analysis of DNA Interactions
Chromatin Accessibility
Conformation Assays
Segment by Application
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epigenome Analysis Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Epigenome Analysis Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Epigenome Analysis Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Epigenome Analysis Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Epigenome Analysis Services in Research Institutes is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Epigenome Analysis Services include Cellcentric, Syndax, Illumina, Merck, QIAGEN, F. Hoffmann-La Roche, Eisai, Abcam and Diagenode, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Epigenome Analysis Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Epigenome Analysis Services.
Report Scope
The Epigenome Analysis Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Epigenome Analysis Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Epigenome Analysis Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cellcentric
Syndax
Illumina
Merck
QIAGEN
F. Hoffmann-La Roche
Eisai
Abcam
Diagenode
Active Motif
Zymo Research Corporation
Thermo Fisher Scientific
Enzo Life Sciences
EpiGentek Group
New England Biolabs
Epizyme
Domainex
Agilent Technologies
AsisChem
Segment by Type
DNA Methylation Analysis
Analysis of DNA Interactions
Chromatin Accessibility
Conformation Assays
Segment by Application
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Epigenome Analysis Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epigenome Analysis Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 DNA Methylation Analysis
1.2.3 Analysis of DNA Interactions
1.2.4 Chromatin Accessibility
1.2.5 Conformation Assays
1.3 Market by Application
1.3.1 Global Epigenome Analysis Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Research Institutes
1.3.3 Pharmaceutical Companies
1.3.4 Biotechnology Companies
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Epigenome Analysis Services Market Perspective (2019-2030)
2.2 Epigenome Analysis Services Growth Trends by Region
2.2.1 Global Epigenome Analysis Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Epigenome Analysis Services Historic Market Size by Region (2019-2024)
2.2.3 Epigenome Analysis Services Forecasted Market Size by Region (2025-2030)
2.3 Epigenome Analysis Services Market Dynamics
2.3.1 Epigenome Analysis Services Industry Trends
2.3.2 Epigenome Analysis Services Market Drivers
2.3.3 Epigenome Analysis Services Market Challenges
2.3.4 Epigenome Analysis Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Epigenome Analysis Services Players by Revenue
3.1.1 Global Top Epigenome Analysis Services Players by Revenue (2019-2024)
3.1.2 Global Epigenome Analysis Services Revenue Market Share by Players (2019-2024)
3.2 Global Epigenome Analysis Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Epigenome Analysis Services Revenue
3.4 Global Epigenome Analysis Services Market Concentration Ratio
3.4.1 Global Epigenome Analysis Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epigenome Analysis Services Revenue in 2023
3.5 Epigenome Analysis Services Key Players Head office and Area Served
3.6 Key Players Epigenome Analysis Services Product Solution and Service
3.7 Date of Enter into Epigenome Analysis Services Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Epigenome Analysis Services Breakdown Data by Type
4.1 Global Epigenome Analysis Services Historic Market Size by Type (2019-2024)
4.2 Global Epigenome Analysis Services Forecasted Market Size by Type (2025-2030)
5 Epigenome Analysis Services Breakdown Data by Application
5.1 Global Epigenome Analysis Services Historic Market Size by Application (2019-2024)
5.2 Global Epigenome Analysis Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Epigenome Analysis Services Market Size (2019-2030)
6.2 North America Epigenome Analysis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Epigenome Analysis Services Market Size by Country (2019-2024)
6.4 North America Epigenome Analysis Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Epigenome Analysis Services Market Size (2019-2030)
7.2 Europe Epigenome Analysis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Epigenome Analysis Services Market Size by Country (2019-2024)
7.4 Europe Epigenome Analysis Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Epigenome Analysis Services Market Size (2019-2030)
8.2 Asia-Pacific Epigenome Analysis Services Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Epigenome Analysis Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Epigenome Analysis Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Epigenome Analysis Services Market Size (2019-2030)
9.2 Latin America Epigenome Analysis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Epigenome Analysis Services Market Size by Country (2019-2024)
9.4 Latin America Epigenome Analysis Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Epigenome Analysis Services Market Size (2019-2030)
10.2 Middle East & Africa Epigenome Analysis Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Epigenome Analysis Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Epigenome Analysis Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cellcentric
11.1.1 Cellcentric Company Detail
11.1.2 Cellcentric Business Overview
11.1.3 Cellcentric Epigenome Analysis Services Introduction
11.1.4 Cellcentric Revenue in Epigenome Analysis Services Business (2019-2024)
11.1.5 Cellcentric Recent Development
11.2 Syndax
11.2.1 Syndax Company Detail
11.2.2 Syndax Business Overview
11.2.3 Syndax Epigenome Analysis Services Introduction
11.2.4 Syndax Revenue in Epigenome Analysis Services Business (2019-2024)
11.2.5 Syndax Recent Development
11.3 Illumina
11.3.1 Illumina Company Detail
11.3.2 Illumina Business Overview
11.3.3 Illumina Epigenome Analysis Services Introduction
11.3.4 Illumina Revenue in Epigenome Analysis Services Business (2019-2024)
11.3.5 Illumina Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck Epigenome Analysis Services Introduction
11.4.4 Merck Revenue in Epigenome Analysis Services Business (2019-2024)
11.4.5 Merck Recent Development
11.5 QIAGEN
11.5.1 QIAGEN Company Detail
11.5.2 QIAGEN Business Overview
11.5.3 QIAGEN Epigenome Analysis Services Introduction
11.5.4 QIAGEN Revenue in Epigenome Analysis Services Business (2019-2024)
11.5.5 QIAGEN Recent Development
11.6 F. Hoffmann-La Roche
11.6.1 F. Hoffmann-La Roche Company Detail
11.6.2 F. Hoffmann-La Roche Business Overview
11.6.3 F. Hoffmann-La Roche Epigenome Analysis Services Introduction
11.6.4 F. Hoffmann-La Roche Revenue in Epigenome Analysis Services Business (2019-2024)
11.6.5 F. Hoffmann-La Roche Recent Development
11.7 Eisai
11.7.1 Eisai Company Detail
11.7.2 Eisai Business Overview
11.7.3 Eisai Epigenome Analysis Services Introduction
11.7.4 Eisai Revenue in Epigenome Analysis Services Business (2019-2024)
11.7.5 Eisai Recent Development
11.8 Abcam
11.8.1 Abcam Company Detail
11.8.2 Abcam Business Overview
11.8.3 Abcam Epigenome Analysis Services Introduction
11.8.4 Abcam Revenue in Epigenome Analysis Services Business (2019-2024)
11.8.5 Abcam Recent Development
11.9 Diagenode
11.9.1 Diagenode Company Detail
11.9.2 Diagenode Business Overview
11.9.3 Diagenode Epigenome Analysis Services Introduction
11.9.4 Diagenode Revenue in Epigenome Analysis Services Business (2019-2024)
11.9.5 Diagenode Recent Development
11.10 Active Motif
11.10.1 Active Motif Company Detail
11.10.2 Active Motif Business Overview
11.10.3 Active Motif Epigenome Analysis Services Introduction
11.10.4 Active Motif Revenue in Epigenome Analysis Services Business (2019-2024)
11.10.5 Active Motif Recent Development
11.11 Zymo Research Corporation
11.11.1 Zymo Research Corporation Company Detail
11.11.2 Zymo Research Corporation Business Overview
11.11.3 Zymo Research Corporation Epigenome Analysis Services Introduction
11.11.4 Zymo Research Corporation Revenue in Epigenome Analysis Services Business (2019-2024)
11.11.5 Zymo Research Corporation Recent Development
11.12 Thermo Fisher Scientific
11.12.1 Thermo Fisher Scientific Company Detail
11.12.2 Thermo Fisher Scientific Business Overview
11.12.3 Thermo Fisher Scientific Epigenome Analysis Services Introduction
11.12.4 Thermo Fisher Scientific Revenue in Epigenome Analysis Services Business (2019-2024)
11.12.5 Thermo Fisher Scientific Recent Development
11.13 Enzo Life Sciences
11.13.1 Enzo Life Sciences Company Detail
11.13.2 Enzo Life Sciences Business Overview
11.13.3 Enzo Life Sciences Epigenome Analysis Services Introduction
11.13.4 Enzo Life Sciences Revenue in Epigenome Analysis Services Business (2019-2024)
11.13.5 Enzo Life Sciences Recent Development
11.14 EpiGentek Group
11.14.1 EpiGentek Group Company Detail
11.14.2 EpiGentek Group Business Overview
11.14.3 EpiGentek Group Epigenome Analysis Services Introduction
11.14.4 EpiGentek Group Revenue in Epigenome Analysis Services Business (2019-2024)
11.14.5 EpiGentek Group Recent Development
11.15 New England Biolabs
11.15.1 New England Biolabs Company Detail
11.15.2 New England Biolabs Business Overview
11.15.3 New England Biolabs Epigenome Analysis Services Introduction
11.15.4 New England Biolabs Revenue in Epigenome Analysis Services Business (2019-2024)
11.15.5 New England Biolabs Recent Development
11.16 Epizyme
11.16.1 Epizyme Company Detail
11.16.2 Epizyme Business Overview
11.16.3 Epizyme Epigenome Analysis Services Introduction
11.16.4 Epizyme Revenue in Epigenome Analysis Services Business (2019-2024)
11.16.5 Epizyme Recent Development
11.17 Domainex
11.17.1 Domainex Company Detail
11.17.2 Domainex Business Overview
11.17.3 Domainex Epigenome Analysis Services Introduction
11.17.4 Domainex Revenue in Epigenome Analysis Services Business (2019-2024)
11.17.5 Domainex Recent Development
11.18 Agilent Technologies
11.18.1 Agilent Technologies Company Detail
11.18.2 Agilent Technologies Business Overview
11.18.3 Agilent Technologies Epigenome Analysis Services Introduction
11.18.4 Agilent Technologies Revenue in Epigenome Analysis Services Business (2019-2024)
11.18.5 Agilent Technologies Recent Development
11.19 AsisChem
11.19.1 AsisChem Company Detail
11.19.2 AsisChem Business Overview
11.19.3 AsisChem Epigenome Analysis Services Introduction
11.19.4 AsisChem Revenue in Epigenome Analysis Services Business (2019-2024)
11.19.5 AsisChem Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Epigenome Analysis Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of DNA Methylation Analysis
Table 3. Key Players of Analysis of DNA Interactions
Table 4. Key Players of Chromatin Accessibility
Table 5. Key Players of Conformation Assays
Table 6. Global Epigenome Analysis Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Epigenome Analysis Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 8. Global Epigenome Analysis Services Market Size by Region (2019-2024) & (US$ Million)
Table 9. Global Epigenome Analysis Services Market Share by Region (2019-2024)
Table 10. Global Epigenome Analysis Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 11. Global Epigenome Analysis Services Market Share by Region (2025-2030)
Table 12. Epigenome Analysis Services Market Trends
Table 13. Epigenome Analysis Services Market Drivers
Table 14. Epigenome Analysis Services Market Challenges
Table 15. Epigenome Analysis Services Market Restraints
Table 16. Global Epigenome Analysis Services Revenue by Players (2019-2024) & (US$ Million)
Table 17. Global Epigenome Analysis Services Market Share by Players (2019-2024)
Table 18. Global Top Epigenome Analysis Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenome Analysis Services as of 2023)
Table 19. Ranking of Global Top Epigenome Analysis Services Companies by Revenue (US$ Million) in 2023
Table 20. Global 5 Largest Players Market Share by Epigenome Analysis Services Revenue (CR5 and HHI) & (2019-2024)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Epigenome Analysis Services Product Solution and Service
Table 23. Date of Enter into Epigenome Analysis Services Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Epigenome Analysis Services Market Size by Type (2019-2024) & (US$ Million)
Table 26. Global Epigenome Analysis Services Revenue Market Share by Type (2019-2024)
Table 27. Global Epigenome Analysis Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 28. Global Epigenome Analysis Services Revenue Market Share by Type (2025-2030)
Table 29. Global Epigenome Analysis Services Market Size by Application (2019-2024) & (US$ Million)
Table 30. Global Epigenome Analysis Services Revenue Market Share by Application (2019-2024)
Table 31. Global Epigenome Analysis Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 32. Global Epigenome Analysis Services Revenue Market Share by Application (2025-2030)
Table 33. North America Epigenome Analysis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 34. North America Epigenome Analysis Services Market Size by Country (2019-2024) & (US$ Million)
Table 35. North America Epigenome Analysis Services Market Size by Country (2025-2030) & (US$ Million)
Table 36. Europe Epigenome Analysis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 37. Europe Epigenome Analysis Services Market Size by Country (2019-2024) & (US$ Million)
Table 38. Europe Epigenome Analysis Services Market Size by Country (2025-2030) & (US$ Million)
Table 39. Asia-Pacific Epigenome Analysis Services Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 40. Asia-Pacific Epigenome Analysis Services Market Size by Region (2019-2024) & (US$ Million)
Table 41. Asia-Pacific Epigenome Analysis Services Market Size by Region (2025-2030) & (US$ Million)
Table 42. Latin America Epigenome Analysis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 43. Latin America Epigenome Analysis Services Market Size by Country (2019-2024) & (US$ Million)
Table 44. Latin America Epigenome Analysis Services Market Size by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Epigenome Analysis Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 46. Middle East & Africa Epigenome Analysis Services Market Size by Country (2019-2024) & (US$ Million)
Table 47. Middle East & Africa Epigenome Analysis Services Market Size by Country (2025-2030) & (US$ Million)
Table 48. Cellcentric Company Detail
Table 49. Cellcentric Business Overview
Table 50. Cellcentric Epigenome Analysis Services Product
Table 51. Cellcentric Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 52. Cellcentric Recent Development
Table 53. Syndax Company Detail
Table 54. Syndax Business Overview
Table 55. Syndax Epigenome Analysis Services Product
Table 56. Syndax Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 57. Syndax Recent Development
Table 58. Illumina Company Detail
Table 59. Illumina Business Overview
Table 60. Illumina Epigenome Analysis Services Product
Table 61. Illumina Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 62. Illumina Recent Development
Table 63. Merck Company Detail
Table 64. Merck Business Overview
Table 65. Merck Epigenome Analysis Services Product
Table 66. Merck Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 67. Merck Recent Development
Table 68. QIAGEN Company Detail
Table 69. QIAGEN Business Overview
Table 70. QIAGEN Epigenome Analysis Services Product
Table 71. QIAGEN Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 72. QIAGEN Recent Development
Table 73. F. Hoffmann-La Roche Company Detail
Table 74. F. Hoffmann-La Roche Business Overview
Table 75. F. Hoffmann-La Roche Epigenome Analysis Services Product
Table 76. F. Hoffmann-La Roche Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 77. F. Hoffmann-La Roche Recent Development
Table 78. Eisai Company Detail
Table 79. Eisai Business Overview
Table 80. Eisai Epigenome Analysis Services Product
Table 81. Eisai Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 82. Eisai Recent Development
Table 83. Abcam Company Detail
Table 84. Abcam Business Overview
Table 85. Abcam Epigenome Analysis Services Product
Table 86. Abcam Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 87. Abcam Recent Development
Table 88. Diagenode Company Detail
Table 89. Diagenode Business Overview
Table 90. Diagenode Epigenome Analysis Services Product
Table 91. Diagenode Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 92. Diagenode Recent Development
Table 93. Active Motif Company Detail
Table 94. Active Motif Business Overview
Table 95. Active Motif Epigenome Analysis Services Product
Table 96. Active Motif Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 97. Active Motif Recent Development
Table 98. Zymo Research Corporation Company Detail
Table 99. Zymo Research Corporation Business Overview
Table 100. Zymo Research Corporation Epigenome Analysis Services Product
Table 101. Zymo Research Corporation Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 102. Zymo Research Corporation Recent Development
Table 103. Thermo Fisher Scientific Company Detail
Table 104. Thermo Fisher Scientific Business Overview
Table 105. Thermo Fisher Scientific Epigenome Analysis Services Product
Table 106. Thermo Fisher Scientific Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 107. Thermo Fisher Scientific Recent Development
Table 108. Enzo Life Sciences Company Detail
Table 109. Enzo Life Sciences Business Overview
Table 110. Enzo Life Sciences Epigenome Analysis Services Product
Table 111. Enzo Life Sciences Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 112. Enzo Life Sciences Recent Development
Table 113. EpiGentek Group Company Detail
Table 114. EpiGentek Group Business Overview
Table 115. EpiGentek Group Epigenome Analysis Services Product
Table 116. EpiGentek Group Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 117. EpiGentek Group Recent Development
Table 118. New England Biolabs Company Detail
Table 119. New England Biolabs Business Overview
Table 120. New England Biolabs Epigenome Analysis Services Product
Table 121. New England Biolabs Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 122. New England Biolabs Recent Development
Table 123. Epizyme Company Detail
Table 124. Epizyme Business Overview
Table 125. Epizyme Epigenome Analysis Services Product
Table 126. Epizyme Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 127. Epizyme Recent Development
Table 128. Domainex Company Detail
Table 129. Domainex Business Overview
Table 130. Domainex Epigenome Analysis Services Product
Table 131. Domainex Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 132. Domainex Recent Development
Table 133. Agilent Technologies Company Detail
Table 134. Agilent Technologies Business Overview
Table 135. Agilent Technologies Epigenome Analysis Services Product
Table 136. Agilent Technologies Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 137. Agilent Technologies Recent Development
Table 138. AsisChem Company Detail
Table 139. AsisChem Business Overview
Table 140. AsisChem Epigenome Analysis Services Product
Table 141. AsisChem Revenue in Epigenome Analysis Services Business (2019-2024) & (US$ Million)
Table 142. AsisChem Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Epigenome Analysis Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Epigenome Analysis Services Market Share by Type: 2023 VS 2030
Figure 3. DNA Methylation Analysis Features
Figure 4. Analysis of DNA Interactions Features
Figure 5. Chromatin Accessibility Features
Figure 6. Conformation Assays Features
Figure 7. Global Epigenome Analysis Services Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Epigenome Analysis Services Market Share by Application: 2023 VS 2030
Figure 9. Research Institutes Case Studies
Figure 10. Pharmaceutical Companies Case Studies
Figure 11. Biotechnology Companies Case Studies
Figure 12. Others Case Studies
Figure 13. Epigenome Analysis Services Report Years Considered
Figure 14. Global Epigenome Analysis Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 15. Global Epigenome Analysis Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 16. Global Epigenome Analysis Services Market Share by Region: 2023 VS 2030
Figure 17. Global Epigenome Analysis Services Market Share by Players in 2023
Figure 18. Global Top Epigenome Analysis Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epigenome Analysis Services as of 2023)
Figure 19. The Top 10 and 5 Players Market Share by Epigenome Analysis Services Revenue in 2023
Figure 20. North America Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. North America Epigenome Analysis Services Market Share by Country (2019-2030)
Figure 22. United States Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Canada Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. Europe Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Europe Epigenome Analysis Services Market Share by Country (2019-2030)
Figure 26. Germany Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. France Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. U.K. Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Italy Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Russia Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Nordic Countries Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Asia-Pacific Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Asia-Pacific Epigenome Analysis Services Market Share by Region (2019-2030)
Figure 34. China Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Japan Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. South Korea Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Southeast Asia Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. India Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Australia Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Latin America Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Latin America Epigenome Analysis Services Market Share by Country (2019-2030)
Figure 42. Mexico Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Brazil Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Middle East & Africa Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Middle East & Africa Epigenome Analysis Services Market Share by Country (2019-2030)
Figure 46. Turkey Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Saudi Arabia Epigenome Analysis Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 48. Cellcentric Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 49. Syndax Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 50. Illumina Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 51. Merck Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 52. QIAGEN Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 53. F. Hoffmann-La Roche Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 54. Eisai Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 55. Abcam Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 56. Diagenode Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 57. Active Motif Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 58. Zymo Research Corporation Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 59. Thermo Fisher Scientific Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 60. Enzo Life Sciences Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 61. EpiGentek Group Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 62. New England Biolabs Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 63. Epizyme Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 64. Domainex Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 65. Agilent Technologies Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 66. AsisChem Revenue Growth Rate in Epigenome Analysis Services Business (2019-2024)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
